NASDAQ:GLUE | Cash Flow Statement | Monte Rosa Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$43.4M
2026-03-31-$44.5M-$37.37M$1.87M-$261M$0.00$328.34M
2025-12-31-$46.14M-$43.01M$767,000.00-$65.07M$0.00$29.62M
2025-09-30-$27.08M
2025-06-30-$12.3M
2025-03-31$46.89M-$45.49M$1.59M-$100.23M$0.00$14,000.00
2024-12-31$13.44M$128.92M$183,000.00-$30.9M$0.00$608,000.00
2024-09-30-$23.86M
2024-06-30-$30.31M
2024-03-31-$31.97M-$38.17M$1.38M$9.85M$0.00$246,000.00
2023-12-31-$33.25M$29.63M$1.69M$14.3M$0.00$25.17M
2023-09-30-$34.88M
2023-06-30-$35.18M
2023-03-31-$32.04M-$23.41M$9.18M$20.33M$0.00$18,000.00
2022-12-31-$30.78M-$23.96M$7.27M-$53.94M$0.00$20.43M
2022-09-30-$27.32M
2022-06-30-$26.47M
2022-03-31-$23.93M-$27.4M$1.69M-$180.52M$0.00$153,000.00
2021-12-31-$23.44M-$14.17M$3.06M-$3.05M$0.00-$135,000.00
2021-09-30-$19.84M
2021-06-30-$18.41M
2021-03-31-$12.28M-$13.82M$2.22M-$2.22M$142.77M
2020-12-31-$19.66M-$8.57M$1.19M-$1.19M-$10,000.00
2020-09-30-$6.56M
2020-06-30-$5.36M
2020-03-31-$4.3M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$38.63M-$22.8M$4.7M-$101.83M$0.00$30.35M
2024-12-31-$72.7M$42M$3.99M-$44.45M$0.00$98.89M
2023-12-31-$135.35M-$43.8M$19.04M$88.8M$0.00$27.49M
2022-12-31-$108.5M-$92.47M$12.91M-$219.22M$0.00$20.47M
2021-12-31-$73.96M-$59.36M$9.73M-$9.65M$0.00$377.56M
2020-12-31-$35.88M-$23.05M$3.39M-$3.39M$60.06M